Reproductive Endocrinology expert witnesses

Reproductive endocrinology and infertility is a recognized subspecialty of obstetrics and gynecology, requiring a dedicated fellowship and a distinct body of clinical knowledge that extends well beyond general women's health practice. Litigation in this area routinely involves questions that only a subspecialist can credibly answer: Was the gonadotropin dosing protocol within the recognized range for this patient's ovarian reserve profile? Did the treating physician respond appropriately when early signs of ovarian hyperstimulation appeared? Was the laboratory's embryo-handling procedure consistent with SART and accreditation standards? Courts and juries are not equipped to answer these questions without expert guidance, and opposing counsel in defense work — or plaintiff attorneys in malpractice matters — will exploit any gap in subspecialty credentialing. Retaining an REI-trained expert witness is not a procedural formality; it is the foundation of the standard-of-care analysis in any serious fertility-related claim.

The cases most frequently seen in this subspecialty fall into several recurring categories. Ovarian hyperstimulation syndrome (OHSS) claims involve allegations that stimulation protocols were excessive or that warning signs were not acted upon in time, resulting in serious patient harm. IVF cycle failure cases may allege that medications were improperly administered, that embryo transfer was performed under suboptimal conditions, or that laboratory quality controls were deficient. Embryo-related claims — including embryo loss, mislabeling, or wrongful destruction — raise both standard-of-care and, in some jurisdictions, novel property and emotional distress theories that require an expert who understands ART laboratory operations from the inside. Delayed diagnosis cases involve conditions such as polycystic ovarian syndrome, endometriosis, premature ovarian insufficiency, or uterine factor infertility where earlier intervention might have preserved fertility. Hormonal therapy adverse event cases involve claims that a medication — often a gonadotropin, GnRH agonist or antagonist, or progesterone preparation — was contraindicated or improperly managed. Each of these categories requires testimony grounded in the specific clinical and laboratory protocols that govern REI practice.

Profile verification for REI experts follows a structured process focused on the credentials that courts and opposing counsel will scrutinize first. Board certification status is confirmed through ABOG's publicly available verification resources, with attention to whether the physician holds the REI subspecialty certificate in addition to general OB/GYN certification. State medical license standing is checked in each jurisdiction where the expert holds or has held a license, including review for active restrictions, probationary conditions, or prior disciplinary actions. Federal exclusion databases are reviewed to identify any Medicare or Medicaid sanction history. The expert's CV is reviewed for consistency between claimed clinical experience, training dates, academic appointments, and publication record. For experts whose practice has included ART program direction, SART membership and program reporting history may be reviewed where publicly accessible. No profile is activated based on self-reported information alone.

An engagement with an REI expert witness typically begins with a record review phase, during which the expert reviews medical records, laboratory logs, stimulation cycle documentation, embryology records, and any relevant communications. This phase often surfaces the factual basis for — or against — the standard-of-care opinion. The expert will then produce a written report or preliminary opinion letter, depending on the jurisdiction's disclosure rules and the stage of litigation. Deposition preparation is a distinct phase and should be planned with adequate lead time; REI subspecialists in active clinical practice have scheduling constraints that differ from full-time expert witnesses. Trial testimony in this subspecialty can involve visual aids explaining stimulation protocols, hormonal assays, or embryo development timelines — materials the expert should be prepared to develop with litigation support. Fees are typically structured as hourly rates for each phase, with a retainer applied at engagement. Confirm at the outset whether the expert has any prior relationship with any party, institution, or treating physician involved in the matter.

Under Federal Rule of Evidence 702 and the Daubert framework — as well as Frye-standard jurisdictions — courts evaluate whether an expert's opinion rests on sufficient facts, reliable methodology, and reasoning that connects the methodology to the facts of the case. In reproductive endocrinology matters, the methodological foundation is typically grounded in published clinical practice guidelines from the American Society for Reproductive Medicine (ASRM), peer-reviewed literature on stimulation protocols and ART outcomes, and laboratory accreditation standards. An REI expert whose opinions align with or consciously depart from these published standards — and who can explain why — is in a stronger position to survive admissibility challenges than one relying solely on clinical experience. Attorneys should ask prospective experts directly about the published sources underpinning their opinions and whether those sources have been subject to peer review. Subspecialty fellowship training, active clinical practice, and a record of peer-reviewed publication each strengthen the admissibility profile of the proposed expert and should be confirmed before designation.